MoneyWorks4Me

Cipla’s arm’s Mahape facility classified as VAI by USFDA

19 May 2025 Evaluate

United States Food and Drug Administration (USFDA) has classified inspection conducted at Cipla’s wholly-owned subsidiary -- Sitec Labs’ analytical testing facility located in Mahape, Navi Mumbai as Voluntary Action Indicated (VAI). USFDA had conducted the inspection at said facility from February 18 to February 20, 2025. 

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. 

Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..